Albert Robichaud is CSO at Sage Therapeutics, Inc. (SAGE). They have made 6 open-market trades across 1 company since 2014, most recently 2023-02-03.
CIK 0001612861
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $1.7M since 2014, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SAGE | 146,680 | $1.3M |
Shares reported on the most recent Form 4, priced at the 2023-02-07 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SAGE | BUY | 2019-12-09 | 2019-12-10 | $64.16 | $1.6M | +15.7% | +17.1% | -31.0% |
| SAGE | SELL | 2017-12-14 | 2017-12-14 | $159.63 | $8.6M | +3.2% | +5.9% | +9.3% |
| SAGE | SELL | 2017-12-14 | 2017-12-14 | $159.43 | $9.6M | +3.2% | +5.9% | +9.3% |
| SAGE | SELL | 2016-07-12 | 2016-07-14 | $40.00 | $880K | +4.3% | -13.1% | -2.1% |
| SAGE | SELL | 2016-01-25 | 2016-01-26 | $40.02 | $1.6M | -16.0% | -18.5% | +0.7% |
| SAGE | SELL · 10b5-1 | 2015-08-03 | 2015-08-04 | $67.06 | $805K | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-07-01 | 2015-07-01 | $72.13 | $1.2M | -30.6% | -2.1% | -2.1% |
| SAGE | SELL · 10b5-1 | 2015-06-01 | 2015-06-02 | $72.79 | $1.2M | -30.6% | -2.1% | -2.1% |
| SAGE | BUY | 2014-07-23 | 2014-07-23 | $18.00 | $72K | -30.6% | -2.1% | -2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.